Zhi Tong Cai Jing·2025-07-29 10:17Core Viewpoint - The company Zhaoyan New Drug (603127) has experienced a significant stock price fluctuation, with a cumulative increase of over 20% in closing prices over three consecutive trading days [1] Summary by Relevant Sections - Stock Price Movement - The company's A-share stock saw a price increase exceeding 20% over three trading days on July 25, 28, and 29, 2025, indicating unusual trading activity [1] - Regulatory Compliance - The stock price movement falls under the category of abnormal trading fluctuations as per the Shanghai Stock Exchange trading rules [1] - Company's Disclosure - Following a self-examination and inquiry with the controlling shareholder and actual controller, the company confirmed that there are no undisclosed significant information as of the date of the announcement [1]